<DOC>
	<DOCNO>NCT00984659</DOCNO>
	<brief_summary>The purpose study evaluate new questionnaire capture patient experience COPD . The information collect used validate Shortness Breath Daily Activities Questionnaire .</brief_summary>
	<brief_title>Validation New Shortness Breath With Daily Activities Questionnaire Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Dyspnea , refer patient `` shortness breath '' `` breathlessness , '' frequently associate decrease functional status , quality life , disability . Currently available questionnaire specifically address shortness breath component COPD . The development patient report outcome questionnaire specifically assess Shortness Breath Daily Activities ( SOBDA ) patient COPD need .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Adults â‰¥ 40 year age Established clinical history COPD ATS/ERS definition Former current smoker &gt; 10 pack year Evidence dyspnea Has respiratory disorder COPD Cancer complete clinical remission Clinically significant cardiovascular , neurological , psychiatric , renal , gastrointestinal , immunological , endocrine , hematological abnormality uncontrolled</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pulmonary Disease , Chronic Obstructive</keyword>
	<keyword>Dyspnea</keyword>
</DOC>